Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis.
about
Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management.Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.Histopathological and Immunophenotypic Features of Ipilimumab-Associated Colitis Compared to Ulcerative Colitis.
P2860
Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Colonic ulcerations may predic ...... imumab-mediated enterocolitis.
@en
Colonic ulcerations may predic ...... imumab-mediated enterocolitis.
@nl
type
label
Colonic ulcerations may predic ...... imumab-mediated enterocolitis.
@en
Colonic ulcerations may predic ...... imumab-mediated enterocolitis.
@nl
prefLabel
Colonic ulcerations may predic ...... imumab-mediated enterocolitis.
@en
Colonic ulcerations may predic ...... imumab-mediated enterocolitis.
@nl
P2093
P2860
P356
P1476
Colonic ulcerations may predic ...... imumab-mediated enterocolitis.
@en
P2093
Animesh Jain
Evan J Lipson
Mark G Lazarev
William H Sharfman
P2860
P304
P356
10.3748/WJG.V23.I11.2023
P407
P577
2017-03-01T00:00:00Z